To focus our efforts and increase our impact, we have designed two umbrella focus areas under the themes Improved Patient Outcomes and Science of Prevention and Detection.
Our Foundation Board is responsible for setting the strategic vision and ensuring the outward representation of the Foundation.
Our board members bring a vast range of knowledge and experience in the worlds of business, law, government, technology, health care, and non-profit management to the task of governing the foundation. They jointly oversee the foundation's activities and help set the strategic vision for the foundation's grant making, geographic focus, spending, investment, management, governance, and professional standards.
Shawn is founder and chairman of the board for Rising Tide Foundation and Rising Tide Foundation for Clinical Cancer Research. Together with his boards, he leads the senior management team of the foundations and their subsidiaries.
A graduate of Wabash College, and a 32nd degree Master Mason, he is also the chairman of several investment committees and sits on the Board for Cancer Treatment Centers of America at Southwestern Regional Medical Center.
As deputy board chairman, Beat utilizes his wealth of knowledge in foundation laws. He has served as Head Physician of the breast cancer department at the Kantonsspital St. Gallen since 2008, and is passionately committed to advancing cancer research.
Hermann is a lawyer by profession, and an expert in both Swiss and German Law. He also has expertise in the general parts of Swiss Code of Obligations, and in particular, the law of contract and unjustified enrichment. During his illustrious career, he served as a junior lawyer and assessor for the Federal State of Hessen, held positions at the ETH Zurich and the University of Zurich, worked as an associate professor at the universities of St. Gallen and Bern.
Wendy is an independent consultant providing strategic counsel to dozens of patient advocacy organizations and life-sciences companies. She has served as President and CEO of the innovative Melanoma Research Alliance, and as a senior executive for the American Cancer Society (ACSCAN). As a member of our board, she brings an extensive network of deep contacts, and more than 30 years of experience in defining and implementing collaborative strategies, working at the top levels of government and within the leadership of the nonprofit health sector.
Prof. Steven Rosen currently serves as the Provost & Chief Scientific Officer; Director, City of Hope Comprehensive Cancer Center and Beckman Research Institute; and Professor of Hematology and Hematopoietic Cell Transplantation. He has completed his medical degree at the Northwestern University Medical School, Chicago, IL. Throughout the years he has held various positions in cancer treatment and research and co-authored more than 450 publications.
Hubert Bertsch is an Austrian entrepreneur and international businessman. He is the owner and CEO of Bertsch Holding GmbH founded in 1925 with several companies in Europe and the CIS.
When Hubert took over the family business, he reorganized the companies allowing each division to focus on their core competencies and creating a strong solid foundation for expansion. He also enlarged the companies’ sphere of actives and continues to create relations to multiple foreign countries and businesses.
Our Advisory Board supports the Foundation Board in its strategic decision-making for grant opportunities.
Our Advisory Board plays a critical role in reviewing and assessing all grant activities of the foundation and offers technical advice and dynamic perspectives to support our Board of Directors on strategy and governance issues.
Joseph advises the board of directors and Executive team on grant selection and strategic decisions for clinical cancer research activities. He is a Professor in the Applied Cancer Research and Drug Discovery Division of the Translational Genomics Research Institute (TGen), an affiliate of City of Hope Cancer Center. He is also the Chief Medical Officer of the International Myeloma Foundation (IMF).
He has been recognized with numerous awards in education, and is in the Mayo Clinic Resident and Fellow Association Hall of Fame as Educator of the Year. He was also recently named in the Top 100 Doctors in the United States.
Dr. Alexandros Papachristofilou is Senior Physician Radiation Oncology at Basel University Hospital. He studied medicine at the Technical University of Munich and Ludwig-Maximilians University. Alexandros is an active clinical researcher and a former Research Fellow at Paul Scherrer Proton Therapy Institute (PSI).